Location: Honolulu, Hawaii Application Deadline: Continuous
Title: Assistant/Associate/Full Professor – Cancer Biology Program Position Number: Pending Hiring Unit: University of Hawai’i Cancer Center Location: Kaka’ako Closing Date: Continuous Tenure Track: Tenure Track Full Time/Part Time: Full Time
This advertisement is for an 11-month, tenure-track faculty position, to begin approximately Summer 2025. Continuation of appointment is contingent upon satisfactory performance. The University of Hawaii Cancer Center(UHCC), an NCI-Designated Cancer Center, is seeking an established investigator with research focused in gastrointestinal, genitourinary, breast, lung, or skin cancers (cancers of high incidence and with disparities in Hawaii), or cancer immunotherapy for a tenure track position in the Cancer Biology Program. The Cancer Biology program hosts scientists who are at the forefront of cancer research in molecular biology, gene x environment interactions, drug development and translational research. Researchers who may interact synergistically with other UHCC researchers, either because of similar research interests or because they contribute expertise in areas that could integrate with current research activities and who have NCI or other National peer reviewed funding, are the ideal candidates. Among the many core facilities and equipment available are ones supporting Genomics and Bioinformatics, Single Cell Genomics, Metabolomics, Analytical Biochemistry, Biostatistics, Pathology, Drug Discovery, Flow Cytometry and Microscopy. Opportunities and infrastructure are also available for translational research. The successful candidate will join a team of diverse and dynamic researchers devoted to groundbreaking research into the underlying mechanisms driving cancer and to developing novel diagnostics and therapeutics for cancer.
Tenure Track Assistant Professor – Metabolic rewiring in cancer drug resistance #BMD007
The University of Chicago’s Ben May Department for Cancer Research is searching for a tenure-track Assistant Professor whose research focuses on the mechanisms of the emergence of cancer drug resistance. In line with the strategic development of tumor metabolism research at the University of Chicago, the appointee will explore how cancers (e.g., breast cancer or prostate cancer) develop resistance to molecularly-targeted therapies by altering utilization of different metabolic pathways. The appointee will also make use of model systems and approaches that are relevant to translation of their findings to the clinic. Application of scientific discoveries to reduce cancer health disparities is also of interest.
We expect the appointee will be proposed for an appointment in the NCI-designated University of Chicago Medicine Comprehensive Cancer Center (UCCCC) (http://cancer.uchicago.edu) and collaborate in multi-disciplinary research with colleagues across the Biological Sciences and Physical Sciences Divisions, the University of Chicago Medical Center and the Pritzker School of Molecular Engineering. The appointee will have access to state-of-the-art core facilities and outstanding graduate students affiliated with numerous degree-granting programs in the biological and physical sciences. The appointee will teach at the undergraduate and/or graduate level. Compensation (including a generous package of fringe benefits) is dependent upon qualifications.
Prior to the start of employment, qualified applicants must have a doctoral degree or equivalent.
To be considered, those interested must apply online through the University of Chicago’s Academic Recruitment job board, which uses Interfolio to accept applications: http://apply.interfolio.com/146469. Applicants must upload a cover letter, curriculum vitae with bibliography, contact information for three references, a short summary of research plans, and a teaching statement. Review of applications ends when the position is filled.
